PER
Click for more information
2.35% 8.7¢ percheron therapeutics limited

I understand the logic of how ALT 1103 has / may have an affect...

  1. cabe6996
    61 Posts.
    clock Created with Sketch.
    13/09/11
    22:14
    Post #: 8955362
    I understand the logic of how ALT 1103 has / may have an affect of reducing IGF-1 being a growth hormone, but I struggle to understand how this same serum/drug may have benefits for other health conditions such as diabetes / breast cancer/
    If a drug developed is proven to minimize the cell which causes organ growth(in primates), how is this related (where is the relationship) to the other benefits as stated above.
    Any input would be Greatly appreciated
    ANP Price at posting: 9.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
AL8 "What is the focus of AL8 and how is management going to attract shareholders to the registry?"
right-arrow Created with Sketch.
NEWS Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
NEWS Hillcrest Partners with Ocean Batteries to Deploy ZVS Invert
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢ 		Change
0.002(2.35%) 		Mkt cap ! $78.43M
Open High Low Value Volume
8.6¢ 8.9¢ 8.5¢ $53.40K 614.3K

Buyers (Bids)

No. Vol. Price($)
1 49999 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 67263 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.